These results are in keeping with those from a recent study that similarly tested for anti-TIF1γ, anti-NXP2, and anti-RNAP III autoantibodies in patients with breast cancer without rheumatic disease [10]. The gene discussed is MORC3; the disease is breast carcinoma.